State Street’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $362M | Buy |
|
|||||
|
2025
Q2 | $367M | Buy |
|
|||||
|
2025
Q1 | $296M | Sell |
|
|||||
|
2024
Q4 | $249M | Buy |
|
|||||
|
2024
Q3 | $269M | Buy |
|
|||||
|
2024
Q2 | $250M | Buy |
|
|||||
|
2024
Q1 | $276M | Buy |
|
|||||
|
2023
Q4 | $249M | Buy |
|
|||||
|
2023
Q3 | $229M | Buy |
|
|||||
|
2023
Q2 | $252M | Sell |
|
|||||
|
2023
Q1 | $301M | Buy |
|
|||||
|
2022
Q4 | $321M | Buy |
|
|||||
|
2022
Q3 | $318M | Buy |
|
|||||
|
2022
Q2 | $321M | Sell |
|
|||||
|
2022
Q1 | $302M | Buy |
|
|||||
|
2021
Q4 | $282M | Buy |
|
|||||
|
2021
Q3 | $211M | Buy |
|
|||||
|
2021
Q2 | $200M | Buy |
|
|||||
|
2021
Q1 | $204M | Buy |
|
|||||
|
2020
Q4 | $118M | Buy |
|
|||||
|
2020
Q3 | $42.8M | Buy |
|
|||||
|
2020
Q2 | $1.98M | Buy |
|